STUDresearch · Peptide
KLOW stack
Also known as
Klow blend · KLOW peptide · GLOW + KPV · BPC-157 TB-500 GHK-Cu KPV · klow 80mg · 50/10/10/10 blend · Hyper Recovery Stack (clinic nickname) · CLO stack (misheard) · KLOW 80 · 5:1:1:1 blend
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Peptide
Lots of talk
Mixed
SubQ
Healing stacks (named blends)
Mixed — the blend is whole-body once injected; some still pin the BPC portion near a complaint.
What people say
KLOW is a nickname for GHK-Cu, BPC-157, TB-500 and KPV in one vial or as four separate products; 50/10/10/10 mg is a common label convention, not one molecule or regulated formula.
Doses people talk about
Rows preserve what users reported, not a recommendation. Component order is GHK-Cu/BPC-157/TB-500/KPV unless stated, and unverified labels plus concurrent stacks limit interpretation.
How it may feel
Early reports include injection-site redness, swelling and itching or marked fatigue; later reports range from firmer skin and fuller hair to no cartilage improvement after six weeks.
Reported total-blend schedule2.5 mg KLOW blend SC 3 times weekly
One user reported this alongside CJC/ipamorelin and retatrutide, so skin, recovery and weight-related attribution was highly confounded; per-component exposure was not stated.
Reported separate-component daily mixGHK-Cu 2.38 mg; BPC-157 240 mcg; TB-500 310 mcg; KPV 310 mcg daily
A commenter described combining separately obtained components after an earlier GHK-Cu/BPC cycle; prior exposure and other care confounded the later report.
Common labeled vial50/10/10/10 mg per vial, about 80 mg total
This is a common GHK-Cu/BPC-157/TB-500/KPV retail label and appeared in the reviewed fatigue thread; it is not a standardized formulation or per-use amount.
Half-life & effect duration
- Half-life in the body
- Whole blendNo single half-life
- GHK-Cu component · community estimateMinutes to about 1 hour
- BPC / TB components · blend-thread estimatesA few hours
- Felt duration people report
- Early accountsSite reactions or extreme fatigue
- Skin reportsChanges around weeks 3–5
- Knee-focused accountNo benefit after 6 weeks
Cycles people discuss
Community blocks commonly span four to twelve weeks, but the blend forces all four components onto one ratio and schedule even though standalone TB-500 and KPV discussions use different timing.
Timing
Preserved notes include morning and bedtime use. Some describe sleep-disrupting injection-site discomfort and a switch to morning; no preferred clock or blend half-life is established.
Stacks
KLOW is already a four-agent stack. Adding separate BPC, TB, GH secretagogues or GLP-1 agents increases overlap and makes benefit, fatigue, skin and injury claims harder to attribute.
Access talk
Three buy identities: RUO 80 mg pre-mixes, clinic Glow+KPV kits, and four separate vials under the nickname. Read each mg.
Labs people mention
Copper / zinc chatter: Same GHK-heavy watch as GLOW — some logs draw copper/zinc every few months. Not a KLOW trial panel.
Watch for
Ratio trap: Fixed 50/10/10/10 can overshoot daily GHK relative to goals or undershoot BPC vs separate-vial injury charts; you cannot titrate one ingredient alone.
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
No parent-compound half-life exists for KLOW as one entity because it is a four-active mixture, and no product-verified combination PK study was established.
The four components have distinct identities and community schedules; reviewed threads described pre-blends and home-combined separate vials without concentration-time measurements.
Unverified products, variable ratios and no controlled four-component human PK prevent a single blend clearance estimate; component timing cannot be averaged into one half-life.
- Reddit r/Peptidesource — KLOW results/side effects (opens in a new tab)Original 50/10/10/10 pre-blend fatigue report and comments describing positive changes around weeks 3–5, no knee/cartilage benefit at six weeks, and a separate daily mix of 2.38 mg GHK-Cu, 240 mcg BPC-157, 310 mcg TB-500 and 310 mcg KPV.Many anonymous users, unverified products, inconsistent ratios and schedules, prior cycles, supplements, skin care, rehabilitation and other agents.
- Reddit r/PeptidePathways — KLOW (opens in a new tab)Original and follow-up comments describing redness, swelling and itching with site variation, plus a later user reporting repeated reactions and subsequent hives/itching after changing products.Unverified products and routes, different users, changing sites and products, and no clinical assessment of whether the blend, excipient or another factor caused reactions.
Felt duration people report
No single felt window emerged: early accounts reported site reactions or extreme fatigue, some skin changes appeared around weeks 3–5, and one knee-focused account reported no benefit after six weeks.
Other accounts included collagen, tretinoin, prior GHK/BPC exposure, rehabilitation, GLP-1 agents, GH secretagogues or different injection sites.
Self-selected reports, inconsistent products and schedules, four active ingredients and extensive co-interventions prevent component attribution or a typical onset estimate.
- Reddit r/Peptidesource — KLOW results/side effects (opens in a new tab)Original 50/10/10/10 pre-blend fatigue report and comments describing positive changes around weeks 3–5, no knee/cartilage benefit at six weeks, and a separate daily mix of 2.38 mg GHK-Cu, 240 mcg BPC-157, 310 mcg TB-500 and 310 mcg KPV.Many anonymous users, unverified products, inconsistent ratios and schedules, prior cycles, supplements, skin care, rehabilitation and other agents.
- Reddit r/PeptidePathways — KLOW (opens in a new tab)Original and follow-up comments describing redness, swelling and itching with site variation, plus a later user reporting repeated reactions and subsequent hives/itching after changing products.Unverified products and routes, different users, changing sites and products, and no clinical assessment of whether the blend, excipient or another factor caused reactions.
- Reddit r/PeptideForum — Current peptide stack using KLOW, CJC/Ipamorelin and Retatrutide (opens in a new tab)Original post: 2.5 mg KLOW blend SC three times weekly while concurrently using CJC-1295/ipamorelin and retatrutide for skin, recovery and fat-loss goals.Deleted/anonymous author, no per-component KLOW ratio, several concurrent agents, diet and training; no clean outcome attribution.
What people say
- Soft-tissue / injury core: Same BPC+TB “Wolverine” anecdotes — tendons, ligaments, muscle strains, post-training soreness — now inside a four-way vial. forum
- Skin / collagen / “glow”: GHK-Cu portion keeps the aesthetic pitch (tone, recovery look, ECM/collagen talk, some hair/scalp adjacency). forum
- Gut / inflammation differentiator: KPV is why people pick KLOW over GLOW — leaky-gut, flare, IBD-adjacent, and “systemic anti-inflammatory” threads. forum
- Post-procedure / med-spa: Clinic and IG content push faster calm-down after lasers, injectables, or minor procedures (repair + copper peptide + anti-inflammatory story). forum
- One-pin convenience: Four peptides without four separate bottles or four morning draws — primary retail reason for pre-blends. forum
- “Gentler than GLOW” marketing: Some vendor pages claim KPV makes the stack easier to tolerate than plain GLOW; that is sales copy, not a head-to-head trial. forum
- Athletic + aesthetic overlap: Framed for both “get back to training” and “look recovered” — high social volume 2025–2026. forum
- 2025–26 pick vs GLOW: KLOW when gut/flare/reactive-skin is the reason for the fourth peptide; GLOW when copper/repair/skin is enough. No blend vs blend trial. forum
- Fighting the ratios: 2026 logs want ~1–2 mg GHK, ~300–500 mcg KPV, higher BPC, and classic weekly TB — the 80 mg vial cannot hit all four at once. Extra BPC/TB on the side is the usual patch. forum
- KPV mechanism lore: Community and vendor writeups cite NF-κB / MAPK dampening and PepT1 gut transport from animal/cell KPV literature — not proof the pre-mixed SC blend recreates oral gut models. animal
Doses people talk about
- Common daily pre-blend band (community charts): roughly ~1.25–2.5 mg GHK-Cu with ~0.25–0.5 mg each of BPC-157, TB-500, and KPV, once daily. Shorthand examples people use: ~1.25/0.25/0.25/0.25 mg (lower) or ~2.5/0.5/0.5/0.5 mg (higher chart). forum
- What people buy (most-cited pre-blend): 50 mg GHK-Cu + 10 mg BPC-157 + 10 mg TB-500 + 10 mg KPV (often written 50/10/10/10, ~80 mg total). Other ratios exist. forum
- How to read doses: Use per-peptide amounts — e.g. ~2 / 0.4 / 0.4 / 0.4 mg (GHK-Cu / BPC / TB / KPV) — not one “total mg of all four.” On a true 50/10/10/10 vial every draw is ~62.5% GHK-Cu by mass. forum
- Mid “GHK-first” talk: Aiming ~1.75–2 mg GHK-Cu with matched minors → about ~2 / 0.4 / 0.4 / 0.4 mg (GHK/BPC/TB/KPV) when the vial really is 50/10/10/10. forum
- If unbundled (separate vials, same four names): BPC ~250–500 mcg/day; KPV ~200–500 mcg/day SC (oral KPV gut talk is a different route story); GHK-Cu ~1–2 mg/day; TB-500 classic ~2–2.5 mg 2×/week load → ~2–2.5 mg weekly maintain. forum
- Schedule culture: Pre-blend = usually daily SC; also 5 on / 2 off and load→lower-frequency maintain charts. forum
- vs GLOW dosing: Same GHK/BPC/TB conversation, plus KPV in the same pin — do not copy a GLOW “three-number” shorthand onto a four-peptide vial without adding KPV. forum
- TB schedule conflict: Daily blend TB is microgram-scale every day; classic TB is multi-mg a few times per week — different pattern. forum
- Mistake to avoid: Quoting only “2 mg KLOW” or “4 mg total blend” without saying which peptide is which mg. Prefer GHK/BPC/TB/KPV ordered numbers. forum
- Ratio fight numbers people actually type: Wanted ~1–2 mg GHK + 300–500 mcg KPV + ~750 mcg BPC + 2 mg TB 2×/week vs what the vial delivers (~2.4 mg GHK with ~480 mcg of each minor at one 2026 log). Convenience vs pin-cushion is the argument. forum
- Titration culture (not a trial): Start toward the low end of the per-peptide band for a week or two, then step toward the mid band if tolerated — still lockstep for all four in a pre-blend. forum
- Framing: Community/vendor blend talk only — not prescribing. “KLOW” is a marketing name; read the mg of each peptide on your label. forum
How it may feel
- Days 1–14: Reports conflict: one 50/10/10/10 pre-blend user described only extreme fatigue after a little over two weeks, while another thread documented redness, swelling and itching during the first days with site-to-site variation. forum
- Weeks 3–6: Reports remain mixed: some described progressive or firmer-skin changes around weeks 3–5, while one knee-focused user reported no cartilage benefit after six weeks. Concurrent collagen, prior blends, rehabilitation and other agents often confounded attribution. forum
- Weeks 4–6 / 4–8: Common full-block lengths for standard aesthetic/repair cycles; skin/collagen claims need more consistency per GHK-heavy community lore. forum
- Weeks 6–12: Longer vendor calculators and “extended” blocks; 12-week plans often budget 2–3 × 80 mg vials depending on daily units. forum
- Blend attribution problem: Harder than single-peptide logs to know which peptide “did” anything — forums still debate separate-vial control for that reason. forum
- After stop: Variable; injuries and gut flares may return with triggers; skin claims more inconsistent than short injury blocks. anecdote
- No change ~4 weeks: Community advice is usually to re-check dose math, site technique, sleep/training, and whether TB would prefer a classic weekly schedule outside the blend — not to blindly double units. forum
- Copper uglies on KLOW: 2026 r/Peptides “horrible skin from Klow” / “copper uglies from GHK-Cu/KLOW” threads — dry, flaky, teenage breakouts, splotchy red, lines looking deeper around weeks 2–6. Attribution is messy because four peptides + tret/skincare. forum
- Uglies vs 4–5 mg GHK math: One April 2026 log at ~15–20 units of 80 mg / 3 mL landed ~3–5 mg GHK — the board’s first reply was “that is not the 2 mg copper band.” forum
Around the dose
- Timing discussion: Daily morning SubQ appears in older blend notes; bedtime use and timing-does-not-matter reports also appear. Neither a default schedule nor the old warm-vial rationale is established. forum
- Training: Not a pre-workout. Most logs pin away from the session (morning, or evening on rest) so a GHK sting and training don’t stack. Post-workout on training days appears; “take it to max the workout” does not. forum
- Rest / PT: Injury-oriented users still credit deload, sleep, and actual rehab more than extra units. Sitting still and waiting for four peptides is a frequent disappointment post. forum
- Gut vs skin job: Gut-first people often want KPV earlier in the day and sometimes unbundle to oral KPV — the pre-blend cannot split jobs. Skin/collagen talk is daily consistency, not a one-rep max. forum
- KLOW vs solo TB: Inside the blend, TB is daily micrograms. Classic TB-500 is a few multi-mg shots per week. Don’t copy the weekly TB chart onto the 80 mg vial. forum
- After: Keep lifting or PT in the block if the complaint allows. Logs that only change the pin and not sleep, protein, or load are the usual “it did nothing” threads. forum
- Avoid: Extra copper peptides on top of a GHK-heavy blend, and weekend-only “when I remember” GHK if the skin story is the point. forum
- KPV AM / GHK PM: Gut-first people unbundle oral or morning KPV so they are not locking KPV to the copper pin. Pre-blend users just pick one daily clock. forum
- Night KLOW: Some prefer bedtime for “overnight repair”; others say the GHK ache wrecks sleep and move it to morning. Wife-kept-her-up posts exist next to “timing doesn’t matter.” forum
- Dose off GHK, cap the copper. 2026 uglies threads treat ~2 mg GHK as the compare number, not 4 mg “total KLOW.” forum
- Don’t run GLOW + KLOW. Same three peptides twice, plus KPV. Pick one blend or unbundle. forum
Cycles people discuss
- Common block: ~4–6 weeks on, 2–4 weeks off (often justified by copper/GHK cycle talk more than hard PK). forum
- Extended: ~8–12 weeks on then multi-week off in longer injury/skin/gut plans. forum
- Clinic-style short: ~~30 days on / ≥~15 days off appears in some regenerative-clinic writeups. forum
- Med-spa series example: Glow+KPV programs sometimes structured ~6 on / 3 off inside a longer series. forum
- Repeat cycles: Multiple series/year in social content; chronic yearly stacking safety is thin. forum
- Copper-only vs KLOW cycle talk: Solo GHK people often run longer; KLOW threads still push on/off because of copper load plus three other APIs. Not a PK law. forum
Timing
- No combo PK: Public pharmacokinetics for the four mixed in one solution are not established; timing culture is stitched from component habits. forum
- Daily injection culture: Matches BPC + KPV + GHK daily practice more than classic TB weekly charts. forum
- TB schedule mismatch: Daily blend draws deliver small TB every day; classic TB-500 talk is still loading multi-mg 2×/week then weekly. Forums argue daily micro-TB may be “wrong” relative to single-peptide tradition — unproven either way for the blend. forum
- Community half-life chatter (components, not blend): GHK-Cu often claimed very short (minutes to ~1 h talk); BPC and TB sometimes loosely cited in the few-hour range in blend threads — these are forum numbers, not a substitute for formal PK tables. forum
- Why “no weekend breaks” arguments exist: Short GHK half-life lore + collagen consistency pitch → 7 days/week dosing in some GHK-heavy protocols; other charts still use 5 on/2 off for lifestyle. forum
- Washout / off periods: Framed around copper clearance and desensitization marketing more than measured multi-peptide terminal half-life. forum
- KPV vs GHK clock (unbundle): 2025–26 logs that split jobs pin KPV (or oral KPV) in the morning and GLOW/GHK in the evening, or KLOW AM plus extra KPV/BPC at night. The pre-mix cannot split those clocks. forum
- “KPV competes with BPC” rumor: Shows up in GLOW-vs-KLOW threads; when asked for a paper, nobody produces one. Treat as forum noise. forum
- KPV route split: Standalone KPV has strong oral gut research interest (animal colitis models) and SC systemic talk; KLOW pre-blends are almost always injectable. Oral KPV + injectable GLOW is a common “DIY unbundle.” animal
More on what it is
- vs GLOW: KLOW ≈ GLOW base + KPV — marketed for gut/inflammation noise on top of repair+skin. forum
- What it is: Named four-peptide research blend: GHK-Cu + BPC-157 + TB-500 + KPV in one vial (or the same four run as separate vials under the KLOW nickname). forum
- Mnemonic: GLOW components (GHK-Cu + BPC + TB) + KPV → “KLOW.” Search traffic often hits the brand name before the four ingredient names. forum
- Default vial talk: Most retail/research-chem labels repeat 80 mg total as 50 mg GHK-Cu + 10 mg KPV + 10 mg BPC-157 + 10 mg TB-500 (often written 50/10/10/10). That is marketing convention, not a regulated standard. forum
- Mass share: On a true 50/10/10/10 vial, GHK-Cu is ~62.5% of every draw; each of KPV, BPC, and TB is ~12.5%. You cannot raise BPC without also raising GHK/KPV/TB in lockstep. forum
- vs GLOW: GLOW is the same regenerative core without KPV (commonly ~70 mg, 5:1:1 GHK:BPC:TB talk). KLOW’s differentiator is the anti-inflammatory KPV pitch (gut/immune/“calm the noise”). forum
- vs Wolverine: Wolverine = BPC-157 + TB-500 only. KLOW = Wolverine + GHK-Cu + KPV. Step-down path: KLOW → GLOW (drop KPV) → Wolverine (drop GHK + KPV). forum
- Not one molecule: Four APIs; compounding pharmacies, med-spa kits, and gray-market lyo vials can use different absolute milligrams even when they still say “KLOW.” Always read the COA/label, not the Instagram name. forum
- Evidence honesty: Individual peptides have preclinical (and limited human/topical GHK) literature; no published clinical trial evaluates the four mixed together as KLOW. Combo claims are synergy marketing + anecdote. forum
- Composition talk: Often marketed near 50/10/10/10 mg GHK-Cu/BPC/TB/KPV class vials — vendor ratios are not universal. forum
- vs GLOW math (2025–26): Same 50/10/10 base, +10 mg KPV, ~80 mg total. GHK share drops from ~71% (GLOW) to ~62.5% (KLOW); absolute GHK stays 50 mg if the label is honest. forum
- 5:1:1:1 shorthand: Forum nickname for 50/10/10/10. Still a vendor convention, not a regulated formula. forum
- July 2026 PCAC is not a KLOW vote: BPC-157, KPV, and TB-500 each got advisory 503A recommendations (reported 8–6–1). GHK-Cu was not on that seven-peptide panel. The four-way mix was never on the ballot. trial
Stacks
- KLOW alone: Already four peptides — default “one stack” product. forum
- Step-down map: Drop KPV → GLOW; drop GHK+KPV → Wolverine (BPC+TB). Useful when cost, copper sting, or schedule fights force simplification. forum
- Unbundle gut focus: Oral or separate KPV + injectable GLOW/Wolverine when people want gut-targeted KPV without locking GHK ratio. forum
- Extra BPC: Some clinic content layers additional BPC for gut-heavy goals on top of a GLOW/KLOW base — risk of overstacking and attribution fog. forum
- Extra TB: Separate TB load/maintain while running a daily blend is discussed when people distrust daily micro-TB. forum
- GH secretagogues: Occasional lifestyle stacks with CJC/Ipamorelin-class recovery routines — heavily confounded. forum
- Avoid mega-stacks: Forum caution against piling more injectables (LL-37, random “healing” peptides, high-dose copper) on top without a reason. forum
- LL-37 adjacency: Sometimes mentioned in inflammation/immune peptide conversations next to KPV — different risk profile; not a default KLOW add-on. forum
- KLOW + extra BPC (or extra TB): 2026 default when the 50/10/10/10 undershoots injury charts. Convenience vial plus a second pin. forum
- GHK-Cu + KPV only: People who drop BPC/TB for cancer-agitation fear or “I just want skin + calm” run the two without calling it KLOW. forum
Access talk
- Three buy identities: RUO 80 mg pre-mixes, clinic Glow+KPV kits, and four separate vials under the nickname. Read each mg. forum
- RUO still the loud path: Three of four ingredients getting a committee nod did not turn Instagram blends into pharmacies. forum
- Not a listed drug and not a PCAC blend. July 23, 2026 PCAC recommended BPC-157, KPV, and TB-500 (reported 8–6–1 each) for the 503A bulks list. Advisory only — not a finished listing, not an approval of “KLOW.” trial
- GHK-Cu missed that panel. Injectable nomination withdrawn; non-injectable GHK-Cu returned to 503A Category 1 in the May 14, 2026 FDA reference update, with PCAC talk before end of February 2027. The copper leg of KLOW is the access gap. trial
Labs people mention
- Copper / zinc chatter: Same GHK-heavy watch as GLOW — some logs draw copper/zinc every few months. Not a KLOW trial panel. forum
- Inflammation story labs: hs-CRP shows up when the pitch is “KPV for systemic noise.” A quieter gut log is still what people compare. forum
Storage notes
- No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
- Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum
Watch for
- Injection-site reactions: Redness, itch, swell, bruise — multi-peptide + copper peptide blends draw frequent local complaints. forum
- GHK sting / histamine lore: Community posts describe intense pin-site sting from GHK-Cu (mast-cell/histamine talk); technique and dilution debates are common; some abandon copper blends for this reason. forum
- Systemic nonspecifics: Transient fatigue, headache, nausea show up in general peptide-stack clinic FAQs — not unique KLOW RCT data. forum
- Copper concern marketing: Guides list copper-toxicity-style watchouts (nausea, jaundice talk) as theoretical flags with chronic GHK-heavy use — not a documented KLOW epidemic; still drives cycle off-periods. forum
- Ratio trap: Fixed 50/10/10/10 can overshoot daily GHK relative to goals or undershoot BPC vs separate-vial injury charts; you cannot titrate one ingredient alone. forum
- TB schedule conflict: Daily blend TB ≠ classic weekly TB loading — unresolved debate. forum
- Identity / quality risk: Four APIs in one vial multiplies mislabel, underfill, and weak COA risk; “KLOW” brand name is not a purity guarantee. forum
- Cost: Large GHK share makes each vial expensive; multi-vial 12-week plans add up fast. forum
- Attribution fog: Four actives + lifestyle confounds make success/failure stories weak evidence. anecdote
- No combo safety package: No FDA approval of KLOW as a drug; no published four-peptide human trial for efficacy or long-term safety. forum
- Research-only labels: Gray-market product pages still say research use only / not for human consumption — treat marketing cycles accordingly. forum
- Not risk-free healing magic: “Hyper recovery” and “heal everything” branding is sales language, not a safety or efficacy dataset. forum
- Copper uglies on the quad blend: Dry/flaky/breakout/“never looked worse after four weeks” is a 2026 KLOW-specific thread, not just solo GHK cream talk. Push-through vs drop-the-dose is the split. forum
- Four APIs, one ugly face: Cannot tell GHK purge from KPV, vehicle, or tret started the same week. Unbundle if you need to know. forum
- Allergy / hypersensitivity: Stop-the-experiment framing for rash, breathing difficulty, or systemic allergic signs appears on vendor caution lists. forum
- Gut oversell: KPV gut claims ride animal NF-κB/PepT1 and colitis models; SC pre-blend is not the same as oral gut-targeted KPV studies. animal
Evidence mix
Mostly community / anecdote tags
Full: every bullet (trial + community). Use Scan for a faster bro-science read.